SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer

Hernandez-Llodra, S; Segales, L; Safont, A; Juanpere, N; Lorenzo, M; Fumado, L; Rodriguez-Vida, A; Cecchini, L; Bellmunt, J; Lloreta-Trull, J

Hernandez-Llodra, S; Lloreta-Trull, J (reprint author), Univ Pompeu Fabra, Dept Hlth & Expt Sci, Passeig Maritim 25-29, Barcelona 08003, Spain.; Lloreta-Trull, J (reprint author), Parc Salut Mar IMIM, Dept Pathol, Passeig Maritim 25-29, Barcelona 08003, S

PROSTATE, 2019; 79 (10): 1156

Abstract

Background ERG fusion-related prostate cancer (PrCa) is the most prevalent oncogenic driver subclass. SPOP, FOXA1, and IDH1 mutations are other three ......

Full Text Link